Edmund Pezalla | Former VP Pharmaceutical Policy and Strategy
Aetna

Appearances:

Day Two @ 09:40

PANEL SESSION: Pricing and reimbursement: guaranteeing market access for precision drugs

•     Collaborating with payers in order to ensure cost containment in personalized health does not affect expanded patient access
•     Optimizing value propositions to allay payer and provider scepticism around the cost-benefit balance of precision medicine 
•     The role of pharmacy benefit managers and pay-for-play programs in precision medicine pathways